EVP& CBO, Ipsen

SVP, Head Corporate Development, Novo Nordisk

Global Head of BD, Daiichii Sankyo

Corporate SVP, Global Head of BD&L, Boehringer Ingelheim

VP & Head, Takeda Business Development

VP,Head of S&E & Transactions, GSK

Executive Director, BD&L, S&E, Merck

Chief DE&I Officer, Merck

Chief DE&I Officer, Johnson & Johnson

VP, Venture Science, Eli Lilly

Associate VP, Venture Science, Eli Lilly

Associate VP, Venture Capital, Eli Lilly

Global Chief DE&I Officer, Regeneron

VP, Head of BD, Alnylam Pharmaceuticals

VP Head of External Innovation M&A, Ginkgo Bioworks

VP, Head US Commercial, Kite Pharma

Director, Business Development, Oncology, Astellas Pharma

Sr. Director Global Partnering, Neurosciences & Rare Diseases, Ipsen

Executive Director, Head of BD&L USA, Boehringer Ingelheim

Managing Director, Boehringer Ingelheim Venture Fund USA

Acting Head of BD&L/Open Innovation, Bayer

SVP, M&A, BridgeBio

SVP, Head of Business Development & Corporate Strategy, Moderna

Biotech Executive, Multiple Biotechs

Gregory Verdine, CEO, Fog Pharma

CEO, Cerevance

CEO, Abliva

VP Program & Alliance Leadership, Mustang Bio

COO & CCO, Gamida Cell

Chief Corporate Affairs Officer, Ovid Therapeutics

CEO, Ovid Therapeutics

VP Corporate Development, Cerevance

President & Founder, OUTbio

CEO, Shorla Oncology

CEO, Coastar Therapeutics

CEO, Orange Grove Bio

Supervisor, Invention Development Unit, National Cancer Institute–NIH

Chief Business Development Officer & Chief Compliance and Legal Officer, Strata Oncology

Chairman, National Foundation

CEO Rejuvenate Bio

CEO, Hemab

Managing Director, Perceptive Advisors

CEO-Partner, Flagship Pioneering

Partner, Pfizer Ventures & VP, Partnering Innovations, Pfizer

Managing Director, M Ventures

VP Venture Investment, J&J Innovation

Managing Director, Sanofi Ventures

Managing Partner, Forbion

General Partner, Canaan Partners

CBO, RTW Investments

Senior Partner, Flagship Pioneering

Managing Director, Vida Ventures

General Partner, Forbion

Partner, Head of Business Development, Apple Tree Partners

Managing Director, Life Sciences, Bain Capital

Principal, Sofinnova Investments

Director, Foresite Capital

Partner, 5AM Ventures

Principal, Atlas Venture Partners

Managing Partner, Graybella Capital

Managing Director, Vertex Ventures

Principal, Deep Track Capital

Principal, venBio Partners

Founder and Managing Director, MPM Capital

Venture Partner, Pathway Bioventures

Managing Director, Back Bay Life Science Advisors

Partner, Foley Hoag

Co-Chair Securities & Capital Markets Practice Group, Mintz

Partner, Morrison & Foerster

Partner, Fox Rothschild

Partner, RSM

Managing Director, Danforth Advisors

Chief Development Officer, Halloran Consulting

Partner, ZS